JG
LXRX icon

Jefferies Group’s Lexicon Pharmaceuticals LXRX Stock Holding History

Jefferies Group’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-43,852
Closed -$182K – 2410
2019
Q4 		$182K Buy
+43,852
New +$169K ﹤0.01% 2280
2017
Q3 		– Sell
-16,593
Closed -$273K – 2500
2017
Q2 		$273K Buy
+16,593
New +$257K ﹤0.01% 1909
2015
Q2 		– Sell
-28,545
Closed -$188K – 3414
2015
Q1 		$188K Buy
28,545
+25,198
+753% +$172K ﹤0.01% 1779
2014
Q4 		$21K Buy
+3,347
New +$27K ﹤0.01% 1868
2014
Q1 		– Sell
-303,663
Closed -$3.81M – 2236
2013
Q4 		$3.81M Buy
303,663
+301,866
+16,798% +$4.8M 0.02% 381
2013
Q3 		$30K Buy
+1,797
New +$30.1K ﹤0.01% 1806

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Jefferies Group's LXRX Position: Q1 2020 in Review

Jefferies Group sold out of Lexicon Pharmaceuticals (LXRX) in Q1 2020, closing a stake of 43,852 shares — an estimated $182K sold.

Jefferies Group first reported a position in LXRX in Q3 2013 and held it in 6 quarters. The position peaked at $3.81M in Q4 2013. 113 funds tracked by Wall St. Rank hold LXRX as of Q1 2020.

  • Jefferies Group reported no remaining Lexicon Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Jefferies Group sold 43,852 Lexicon Pharmaceuticals shares in Q1 2020, an estimated $182K.
  • Jefferies Group first reported a position in Lexicon Pharmaceuticals in Q3 2013 and held it in 6 quarters.
  • Jefferies Group's Lexicon Pharmaceuticals position peaked at $3.81M in Q4 2013.
  • 113 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q1 2020.

Based on Jefferies Group's 13F filing for Q1 2020, filed 15 May 2020.